GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Research & Development

Daito Pharmaceutical Co (TSE:4577) Research & Development : 円0 Mil (TTM As of Feb. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Daito Pharmaceutical Co's Research & Development for the three months ended in Feb. 2024 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2024 was 円0 Mil.


Daito Pharmaceutical Co Research & Development Historical Data

The historical data trend for Daito Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Research & Development Chart

Daito Pharmaceutical Co Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Daito Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Daito Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daito Pharmaceutical Co  (TSE:4577) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Daito Pharmaceutical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Daito Pharmaceutical Co (TSE:4577) Business Description

Traded in Other Exchanges
N/A
Address
326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co (TSE:4577) Headlines

No Headlines